# Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes

> **NCT00692237** · PHASE4 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 59 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Endothelial Dysfunction

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00692237
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692237, "Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00692237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*